Glycine is another common addition, with the tirzepatide glycine combination showing potential for enhanced nausea management and metabolic support
It contains 0.9% benzyl alcohol as a preservative, which inhibits bacterial growth and keeps your reconstituted solution safe for the 3 to 4 weeks you will be drawing from the vial
The new Guideline: Clarifying the new BSH Guidelines The Guideline has been produced to deal with the current Covid-19 pandemic
The best results come from catching small nerve damage early, fixing the root causes (like blood sugar control), avoiding toxins, and starting therapies that protect or rebuild nerves
Without treatment, this leads to megaloblastic anaemia and potentially serious neurological complications
As GLOW has no trial-established dose, the derived range is 1.4-4.2 mg per injection: Low Dose: 1.4 mg (1 mg GHK-Cu + 200 mcg BPC-157 + 200 mcg TB-4) Standard Dose: 2.8 mg (2 mg GHK-Cu + 400 mcg BPC-157 + 400 mcg TB-4) Elevated Dose: 4.2 mg (3 mg GHK-Cu + 600 mcg BPC-157 + 600 mcg TB-4) What is the GLOW dose per day